Annabelle A Okada. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useBiological TherapyHumansInfliximabInterferon alpha-2Interferon-alpha/adverse effectsInterferon-alpha/therapeutic useRecombinant ProteinsUveitis/therapy
Substances: See more » Antibodies, MonoclonalInterferon alpha-2Interferon-alphaRecombinant ProteinsInfliximab
Year: 2010 PMID: 20457989 DOI: 10.1001/archophthalmol.2010.47
Source DB: PubMed Journal: Arch Ophthalmol ISSN: 0003-9950